Pharmaceutical

Japan grants patent for BioArctic’s Parkinson’s disease antibody

Japan has granted a new drug substance patent for BioArctic’s monoclonal antibody (mAb), BAN0805, to treat Parkinson’s disease.

Aug 24, 2023 - 20:00
Japan grants patent for BioArctic’s Parkinson’s disease antibody
Japan has granted a new drug substance patent for BioArctic’s monoclonal antibody (mAb), BAN0805, to treat Parkinson’s disease.
Read the original article

Tags:

Previous Article

FORE Biotherapeutics raises funding to expedite plixorafenib development

Next Article

Dizal receives approval in China for NSCLC therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Narcan manufacturer aims to price over-the-counter kit under $50

STAT+: Narcan manufacturer aims to price over-the-count...

Apr 21, 2023

ASCO 2024: MediLink’s NSCLC and breast cancer ADC shows early safety success

ASCO 2024: MediLink’s NSCLC and breast cancer ADC shows...

May 25, 2024

STAT+: In early trial, drug appears to reduce harmful protein buildup in heart

STAT+: In early trial, drug appears to reduce harmful p...

May 21, 2023